Orion Oyj (LTS:0M2O) EPS (Basic): €3.76 (TTM As of Mar. 2026)


LTS:0M2O Orion Oyj LTS:0M2O
95 GF Score
Price €69.93
GF Value €69.60
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Orion Oyj EPS (Basic)?

Orion Oyj LTS:0M2O +0.43% 95 EPS (Basic) is €3.76 as of Mar. 2026. GuruFocus rates LTS:0M2O with a GF Score™ of 95/100 and a GF Value™ of €69.60 (Fairly Valued). The stock has 2 warning signs investors should review.

Orion Oyj's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was €0.64. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was €3.76.

Orion Oyj's EPS (Diluted) for the three months ended in Mar. 2026 was €0.64. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was €3.76.

Orion Oyj's EPS without NRI for the three months ended in Mar. 2026 was €0.64. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 3.76.

During the past 12 months, Orion Oyj's average EPS without NRIGrowth Rate was 52.20% per year. During the past 3 years, the average EPS without NRI Growth Rate was 12.70% per year. During the past 5 years, the average EPS without NRI Growth Rate was 16.20% per year. During the past 10 years, the average EPS without NRI Growth Rate was 6.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Orion Oyj's highest 3-Year average EPS without NRI Growth Rate was 445.40% per year. The lowest was -76.70% per year. And the median was 2.60% per year.

Orion Oyj  (LTS:0M2O) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Orion Oyj EPS (Basic) Related Terms

Orion Oyj EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Orion Oyj's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Orion Oyj EPS (Basic) Chart

Orion Oyj Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.38 2.49 1.54 2.35 3.56

Orion Oyj Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.44 0.59 0.68 1.85 0.64
LTS:0M2O
95GF Score
Orion Oyj LTS:0M2O
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Orion Oyj EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Orion Oyj's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(500.3-0)/140.657
=3.56

Orion Oyj's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(90.4-0)/140.734
=0.64

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €3.76

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of €3.76 mean?
Orion Oyj (LTS:0M2O) has a EPS (Basic) of €3.76 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Orion Oyj and its competitors.
Is Orion Oyj's EPS (Basic) too high?
Orion Oyj's current EPS (Basic) is €3.76. Overall, Orion Oyj has a GF Score™ of 95/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Orion Oyj's EPS (Basic) compare to LLY and JNJ?
Orion Oyj's EPS (Basic) of €3.76 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Orion Oyj and its competitors. Orion Oyj's current EPS (Basic) is €3.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orion Oyj stock overvalued right now?
Based on GuruFocus' analysis, Orion Oyj (LTS:0M2O) is currently considered Fairly Valued. The stock's GF Value™ is €69.60, compared to a current price of €69.93 — trading 0.5% above its estimated fair value. The current EPS (Basic) is €3.76. Orion Oyj's overall GF Score™ is 95/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Orion Oyj (LTS:0M2O), the current EPS (Basic) is €3.76 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Orion Oyj (LTS:0M2O) Overvalued in 2026?

Based on GuruFocus' analysis, Orion Oyj stock appears to be overvalued. The current stock price of €69.93 is trading 0.5% above its estimated GF Value™ of €69.60. GuruFocus considers Orion Oyj to be Fairly Valued.

Key valuation signals for LTS:0M2O:

  • EPS (Basic): €3.76
  • GF Value™: €69.60 vs. price of €69.93 (0.5% above fair value)
  • GF Score™: 95/100 with 2 warning signs

No single metric tells the full story. See the LTS:0M2O stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Orion Oyj Business Description

Address Orionintie 1, Espoo, FIN, FI-02200
Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company predominantly focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. The company mainly serves Finland but also has a presence in other European countries, North America and other countries.
95GF Score

Get the complete analysis for LTS:0M2O

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€69.93
Price
€69.60
GF Value